Neuroscience
Genome-Wide Association Study
100%
Progressive Supranuclear Palsy
62%
Frontotemporal Dementia
62%
Putamen
61%
Parkinson's Disease
50%
Multiple System Atrophy
50%
Basal Ganglia
50%
Dopaminergic
50%
Riluzole
50%
Parkin
50%
Chromosome 13
50%
Substantia nigra
50%
Nervous System Disorder
50%
Transcriptome
50%
Transcriptomics
50%
Expression Quantitative Trait Loci
50%
Cell Specificity
50%
RNA Processing
50%
Gene Expression
50%
Cluster Headache
50%
Exon
50%
Neurodegeneration
50%
Microtubules
50%
Tauopathy
50%
Amyloid Protein
50%
Monoclonal Antibody
50%
Parkinsonism
25%
Alzheimer's Disease
22%
Cell Loss
21%
Placebo
16%
Corticobasal Degeneration
12%
Polyphagia
12%
Pick's Disease
12%
Chromosome 2
12%
Chromosome 6
12%
Chromosome 1
12%
Behavior (Neuroscience)
12%
Antipsychotic
12%
Episodic Memory
12%
Amyotrophic Lateral Sclerosis
12%
Memory Disorder
12%
Typical Antipsychotic
12%
Disinhibition
12%
Tau Protein
12%
Chromosome 17
12%
Primitive Reflexes
12%
Pyroglutamic Acid
10%
Arginine
10%
Cell Death
10%
Central Nervous System
10%
Biochemistry, Genetics and Molecular Biology
Genome-Wide Association Study
100%
Genetics
83%
Regulatory Site
50%
Expression Quantitative Trait Loci
50%
Tau
50%
Monoclonal Antibody
50%
Genome Sequencing
50%
Genetic Divergence
50%
Genomics
50%
Transcriptomics
50%
Cell Specificity
50%
Transcriptome
50%
Allele
50%
Gene Expression
50%
RNA Processing
50%
Isoform
35%
Proband
33%
Chromosome 6
33%
Chromosome 2
33%
Chromosome 1
33%
Exon
21%
Genetic Predisposition
16%
Quality Control
16%
Single-Nucleotide Polymorphism
16%
Exome Sequencing
16%
Mitochondrial Genome
16%
Gene Set Enrichment
16%
Pedigree
16%
Artificial Neural Network
16%
Clinical Decision Making
16%
Splice Site Mutation
7%
Missense
7%
Tau Protein
7%
Chromosome 17
7%
Medicine and Dentistry
Riluzole
50%
Shy-Drager Syndrome
50%
Parkinson's Disease
50%
Parkin
50%
Disease
50%
Progressive Supranuclear Palsy
50%
Placebo
16%
Putamen
11%
Cell Loss
11%
Log Rank Test
8%
Diseases
8%
Drug Effect
8%
Signal Analysis
5%
Magnetic Resonance Imaging
5%
Stereotypic Movement Disorder
5%
Positron Emission Tomography
5%
